Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Research Article Volume 4 Issue 10

Deciphering the Healthcare Expense with Focus on the Real Cost of Doctors to Patients in India

Sumangala Bhat K*

Dextrose Technologies Pvt. Ltd., Bengaluru, India

*Corresponding Author: Sumangala Bhat K, Dextrose Technologies Pvt. Ltd., Bengaluru, Karnataka, India.

Received: July 09, 2020; Published: September 11, 2020

×

Abstract

  Indian healthcare service is dominated by the private sector and public funding for healthcare is minimal. The increasing cost of healthcare services brings in hardships to the underprivileged both in terms of accessibility and affordability, pushing many families into debt traps. Despite several survey and analysis reports available on various aspects of healthcare service in India, a practical analysis of the cost components and their relative contribution to the hospital bills is scanty. This study has been carried out considering the criticality of finding the real cost enhancement components of healthcare. Hospital bills of random cases from India and abroad have been subjected for cost-split analysis under four heads like diagnostics, doctors’ consultation fees, medicines, and hospital facilities. The study has revealed hospital facilities as the top-ranking cost component (45%) followed by medicines (26%), diagnostics (24%) and doctors’ consultation (5%) in the Indian context. The pattern is slightly different in the other countries, with hospital facilities on top (45%), followed by diagnostics (22%), doctors’ consultation fees (19%) and medicines (14%). Hence there is a contrast in the hospital fees components other than hospital facilities between India and other countries compared. Doctors’ consultation fees ranked the least in India and last but one in other countries, with a large difference between them. Costs of the medicines and diagnostics are the real components contributing to the enhanced cost of hospital expenses in India.

Keywords: Hospital Fees; Cost-Split Analysis; Diagnostics; Medicines; Hospital Facilities

×

References

  1. Srinath P., et al. “A Qualitative and Quantitative Analysis of Public Health Expenditure in India: 2005-06 to 2014-15”. The Takshashila Institution, Working paper (2018).
  2. Rao N. “Who is paying for India’s healthcare?” (2018).
  3. Sengupta A and Nundy S. “The private health sector in India: Is burgeoning, but at the cost of public health care”. British Medical Journal 19 (2005): 1157-1158.
  4. Chatterjee S., et al. “Unit Cost of Medical Services at Different Hospitals in India”. PLoS ONE7 (2013): e69728.
  5. Mathur N., et al. “A comparative study to analyse the cost of curative care at primary health centre in Ahmedabad”. Indian Journal of Community Medicine 35 (2010): 153-158.
  6. Anand K., et al. “Cost analysis of a primary health centre in northern India”. The National Medical Journal of India 6 (1993): 160-163.
  7. Krishnan A., et al. “Cost of curative pediatric services in public sector setting”. Indian Journal of Pediatrics 72 (2005): 657-660.
  8. Sur D., et al. “Treatment cost for typhoid fever at two hospitals in Kolkata, India”. Journal of Health, Population and Nutrition 27 (2009): 725-732.
  9. Ostenbrink JB., et al. “Unit costs of inpatient hospital days”. Pharmacoeconomics 21 (2003): 263-271.
  10. Blomqvist A snd Busby C. “Paying Hospital-Based Doctors: Fee for Whose Service?” C.D. Howe Institute Commentary (2013): 392.
  11. https://www.google.com/search?q=vedant+hospital+bill
  12. https://milaap.org/fundraisers/
  13. https://www.google.com/search?q=appolo+bill
  14. https://www.edudharma.com/fundraiser/
  15. https://gogetfunding.com/
  16. https://www.gofundme.com/
  17. https://give.asia/campaign/
  18. Bhat KS. “Consultation fees of Indian doctors: the myth demystified”. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)5 (5) (2020): 57-60.
  19. “Drug price control has led to increase in price of regulated medicines: Survey” (2020).
  20. Dean EB. “Who Benefits from Pharmaceutical Price Controls? Evidence from India”. CGD Working (2019): 509.
  21. Narula S. “Current Drug Pricing Status in India”. Pharmacoeconomics 1 (2015): e101.
  22. The Drugs (Price Control) Order (2013).
  23. Pilla V. “Govt. push to cap price of essential diagnostic tests to impact path labs, hospitals (2018).
  24. Bhuyan A. “India begins making a list of essential diagnostics whose prices could be capped (2018).
×

Citation

Citation: Sumangala Bhat K. “Deciphering the Healthcare Expense with Focus on the Real Cost of Doctors to Patients in India". Acta Scientific Medical Sciences 4.10 (2020): 07-10.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


Contact US





ht Side bar -->